領展(00823.HK):已採必要措施確保符合「疫苗通行證」要求
「疫苗通行證」今日(24日)起生效,領展(00823.HK)表示,轄下的75個商場和52個鮮活街市已做好準備,採取一系列必要措施,確保符合規例要求及操作程序能夠順利實施。有關措施包括向旗下的所有商戶發出通知,提醒員工上班值勤需要有接種疫苗紀錄。
此外,領展已於商場和鮮活街市的主要出入口張貼「安心出行」二維碼及告示,提醒市民進入商場或街市時,必須使用「安心出行」應用程式。部分二維碼亦已爲視障人士套上凸字膠套。
領展及其街市整體承租商今起分批向旗下52個鮮活街市的租戶,免費派發抗原快速測試套裝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.